RP appears more protective than RT among men with actively treated incidental prostate cancer. Patients with higher-grade incidentally discovered prostate cancer (IPCa) may have better outcomes if ...

Prostatectomy and radiation therapy show no survival difference for low-risk prostate cancer, but higher-risk cases require careful treatment consideration. The ProtecT trial supports active ...

LAS VEGAS -- Focused ultrasound ablation for prostate cancer proved at least equivalent to radical prostatectomy for failure-free survival, according to a randomized trial reported here. After 3 years ...

Fifteen-year outcomes of external radiation with or without 6 months of neoadjuvant deprivation therapy for intermediate risk prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Men diagnosed with high-risk localized prostate cancer now have trial-level evidence that adding the drug apalutamide to ...

Men treated for prostate cancer after surgery now have clearer evidence that extending hormone therapy from six months to two ...

A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first ...

SAN FRANCISCO — A gene signature panel could help identify men with localized prostate cancer who would benefit from radiotherapy dose escalation in both the definitive and salvage settings, according ...

According to data from two phase III trials presented at this year's American Society of Clinical Oncology Genitourinary Cancers Symposium, patients with high-risk prostate cancer had a significantly ...

Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium. This ...

Overview on the use of androgen deprivation therapy (ADT) added to salvage radiation therapy (SRT) for prostate cancer patients with biochemical recurrence after prostatectomy. Th ...